Non-Communicable Disease
14
4
5
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Early Life Intervention in Pediatrics Supported by E-health - SMOKE
The Impact of Oral Health in HIV Patients on Antiretroviral Therapy
Impact of Hand Rub Placement on Patient Trust and Disease Stigma
Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes
Early Life Intervention in Pediatrics Supported by E-health
Post-acute COVID-19 Sequelae in Denmark
Exercise Prescription Via Telerehabilitation for Older Adults With Cardiopulmonary Disease in Antioquia, Colombia
Make My Day - a Stroke Prevention Program
Understanding Risk Factors for Progressive Chronic Kidney Disease in Malawi
Rural South and Southeast Asia Household Health Survey
FRESHAIR4Life: Building the Case for Action
Measuring Quality in Colorectal Cancer Surgery in Low- and Middle-income Countries
Effects of Primary Prevention in Elderly People-The Healthy Aging Initiative